New Delhi: With a view to make inspection of drug production more efficient, American health regulator US Food and Drug Administration (USFDA) is looking to set up offices in different parts of India.
According to sources, the US Food and Drug Administration has submitted a proposal to the government for setting up offices in three cities Mumbai, Delhi and Hyderabad and at the same time is interested in working in collaboration with its Indian counterpart Drug Controller General of India.
“Presently, USFDA is waiting for the Health Ministry’s response,” a source added. Confirming the developments, Indian Pharmaceutical Alliance (IPA) general secretory, DG Shah said the USFDA officials have had discussions with the industry associations.
In February, the officials had come to India for follow up visits after their trip to the country in September last year. The delegation had met senior health ministry officials, including health secretary to discuss the plan to establish three offices in the country. Similar initiatives have been outlined for China too.
The American regulator has expressed desire to work in close cooperation with the drug regulator DCGI and both are planning to made joint inspections in the country, sources added.
Currently, USFDA inspects facilities in India on a periodic basis and comes with prior notices to ensure that these units comply with the good manufacturing practices.